Sally Beauty Holdings, Inc.
For the period ended Jun 30, 2026. Filed Aug 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 3, 2026
SBH$20.54+5.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Nine Months Ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash Flows from Operating Activities: | ||
| Net earnings | $142,334 | $145,947 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | ||
| Depreciation and amortization | 75,135 | 75,593 |
| Share-based compensation expense | 18,096 | 14,800 |
| Amortization of deferred financing costs | 1,437 | 1,609 |
| Loss on early extinguishment of debt | 441 | 943 |
| Impairment of long-lived assets | 418 | 3,222 |
| Gain on sale of property and other | — | (26,641) |
| Gain on divestiture of subsidiary | — | (768) |
| Deferred income taxes | 7,657 | (6,846) |
| Changes in: | ||
| Trade accounts receivable | 5,248 | 4,028 |
| Accounts receivable, other | 14,926 | (6,836) |
| Inventory | (10,259) | 34,193 |
| Other current assets | 2,086 | 3,954 |
| Other assets | (6,396) | 506 |
| Operating leases, net | 5,026 | (10) |
| Accounts payable and accrued liabilities | (4,592) | (74,571) |
| Income taxes payable | (3,976) | (14,120) |
| Other liabilities | (120) | (1,051) |
| Net cash provided by operating activities | 247,461 | 153,952 |
| Cash Flows from Investing Activities: | ||
| Payments for property and equipment | (84,257) | (59,271) |
| Proceeds from sale of property and other | — | 43,574 |
| Proceeds from divestiture of subsidiary | — | 3,128 |
| Acquisitions, net of cash acquired | — | (371) |
| Net cash used by investing activities | (84,257) | (12,940) |
| Cash Flows from Financing Activities: | ||
| Proceeds from ABL Facility | — | 466,000 |
| Repayments of long-term debt and ABL Facility | (60,000) | (564,122) |
| Debt issuance costs | — | (1,535) |
| Proceeds from stock options exercised | 698 | 403 |
| Payments for common stock repurchased | (71,937) | (33,338) |
| Employee withholding taxes paid related to net share settlement of equity awards | (7,345) | (5,271) |
| Net cash used by financing activities | (138,584) | (137,863) |
| Effect of foreign exchange rate changes on cash and cash equivalents | (682) | 1,690 |
| Net increase in cash and cash equivalents | 23,938 | 4,839 |
| Cash and cash equivalents, beginning of period | 149,162 | 107,961 |
| Cash and cash equivalents, end of period | $173,100 | $112,800 |
| Supplemental Cash Flow Information: | ||
| Interest paid | $32,097 | $38,769 |
| Income taxes paid | $48,236 | $75,391 |
| Capital expenditures incurred but not paid | $8,497 | $8,480 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.